| Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size EJ Kuo, RR Salem Annals of surgical oncology 20, 2815-2821, 2013 | 226 | 2013 |
| Molecular genetic mining of the Aspergillus secondary metabolome: discovery of the emericellamide biosynthetic pathway YM Chiang, E Szewczyk, T Nayak, AD Davidson, JF Sanchez, HC Lo, ... Chemistry & biology 15 (6), 527-532, 2008 | 226 | 2008 |
| Effectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a randomized clinical trial MJ Livhits, CY Zhu, EJ Kuo, DT Nguyen, J Kim, CH Tseng, AM Leung, ... JAMA oncology 7 (1), 70-77, 2021 | 135 | 2021 |
| Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis EJ Kuo, P Goffredo, JA Sosa, SA Roman Thyroid 23 (10), 1305-1311, 2013 | 101 | 2013 |
| Risk factors associated with reoperation and disease-specific mortality in patients with medullary thyroid carcinoma EJ Kuo, S Sho, N Li, KA Zanocco, MW Yeh, MJ Livhits JAMA surgery 153 (1), 52-59, 2018 | 80 | 2018 |
| End-organ effects of primary hyperparathyroidism: a population-based study Y Assadipour, H Zhou, EJ Kuo, PI Haigh, AL Adams, MW Yeh Surgery 165 (1), 99-104, 2019 | 65 | 2019 |
| Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients EJ Kuo, SA Roman, JA Sosa Surgery 154 (6), 1246-1254, 2013 | 62 | 2013 |
| Gene expression classifier vs targeted next-generation sequencing in the management of indeterminate thyroid nodules MJ Livhits, EJ Kuo, AM Leung, J Rao, M Levin, ML Douek, KR Beckett, ... The Journal of Clinical Endocrinology & Metabolism 103 (6), 2261-2268, 2018 | 54 | 2018 |
| Gene expression classifier vs targeted next-generation sequencing in the management of indeterminate thyroid nodules MJ Livhits, EJ Kuo, AM Leung, J Rao, M Levin, ML Douek, KR Beckett, ... The Journal of Clinical Endocrinology & Metabolism 103 (6), 2261-2268, 2018 | 54 | 2018 |
| Surgery for primary hyperparathyroidism: adherence to consensus guidelines in an academic health system EJ Kuo, MA Al-Alusi, L Du, A Shieh, MJ Livhits, AM Leung, MW Yeh Annals of surgery 269 (1), 158-162, 2019 | 43 | 2019 |
| Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension EJ Kuo, WJ Thi, F Zheng, KA Zanocco, MJ Livhits, MW Yeh Thyroid 27 (12), 1544-1549, 2017 | 40 | 2017 |
| Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism S Sho, EJ Kuo, AC Chen, N Li, MW Yeh, MJ Livhits Annals of Surgical Oncology 26, 539-546, 2019 | 38 | 2019 |
| Adrenal teratoma: a case series and review of the literature EJ Kuo, AE Sisk, Z Yang, J Huang, MW Yeh, MJ Livhits Endocrine Pathology 28, 152-158, 2017 | 29 | 2017 |
| Evaluation of a recently described risk classification scheme for pancreatic fistulae development after pancreaticoduodenectomy without routine post-operative drainage JW Kunstman, E Kuo, AL Fonseca, RR Salem HPB 16 (11), 987-993, 2014 | 21 | 2014 |
| Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules EJ Kuo, JX Wu, KA Zanocco Surgery 164 (6), 1330-1335, 2018 | 19 | 2018 |
| Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules EJ Kuo, JX Wu, KA Zanocco Surgery 164 (6), 1330-1335, 2018 | 19 | 2018 |
| Recent pregnancy is not associated with high-risk pathological features of well-differentiated thyroid cancer AC Chen, MJ Livhits, L Du, JX Wu, EJ Kuo, MW Yeh, AM Leung Thyroid 28 (1), 68-71, 2018 | 16 | 2018 |
| Nonoperative management of differentiated thyroid cancer in California: a population-level analysis of 29,978 patients EJ Kuo, JX Wu, N Li, KA Zanocco, MW Yeh, MJ Livhits Endocrine Practice 23 (10), 1262-1269, 2017 | 13 | 2017 |
| Biochemical dynamics of untreated primary hyperparathyroidism: an observational study MW Yeh, H Zhou, EJ Kuo, AL Adams, N Li, PI Haigh Endocrine Practice 25 (5), 470-476, 2019 | 7 | 2019 |
| Risk factors for readmission after parathyroidectomy for renal hyperparathyroidism JD Lee, EJ Kuo, L Du, MW Yeh, MJ Livhits World Journal of Surgery 43 (2), 534-539, 2019 | 7 | 2019 |
